Clinical Trial Update: A Study of Sibutramine in Overweight Adolescents to Assess Weight Loss and Safety. [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating the weight loss and safety of sibutramine in overweight adolescents has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• Meridia (sibutramine)

Snippet

Sponsor: Abbott | Conditions: Obesity | Phase 3 | Status: COMPLETED